News Calliditas hits $90m jackpot as biotech IPO craze continues Richard Staines Biotech, biotech IPO, Calliditas, IgA nephropathy, Rare diseases 0 Comment Swedish biotech Calliditas has raised $90 million in an upsized US IPO and private placement, valuing the rare kidney and liver disease Share X Calliditas hits $90m jackpot as biotech IPO craze continues https://pharmaphorum.com/news/calliditas-hits-90m-jackpot-as-biotech-ipo-craze-continues/
Biotech, biotech IPO, Calliditas, IgA nephropathy, Rare diseases
0 Comment
